Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Harbor vs Queen RX

By GLP-1 ScorecardUpdated

HarborFactor scores not reassessed.
Site position #94

Higher score

Queen RXFactor scores not reassessed.
Site position #210

Lower score

Score comparison

Harbor has the higher recorded score — 72/100 to 66.3/100.

Harbor grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Harbor is a physician-led telehealth platform offering compounded semaglutide (from $99/mo) and compounded tirzepatide (from $149/mo) — among the lowest headline prices in the market.

Before you choose

Before comparing the headline prices, the Harbor review and the Queen RX review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, Harbor vs Rejuve Meds and NewSelf vs Queen RX compare each of them with another graded program, and the list of alternatives to Harbor ranks the programs closest to Harbor on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the System Labs review covers one graded close to these two, at 68.4/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueQueen RX +3
74
77
Dose & formulationHarbor +7
64
57
Clinical oversightHarbor +20
89
69
Labs & monitoringHarbor +10
63
53
FulfillmentHarbor +6
81
75
Contract termsQueen RX +14
47
61
Harbor · top barQueen RX · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricHarborQueen RX
WeighScore72/10066.3/100
GradeCC
Site position#94#210
Semaglutide$99/mo (starting dose, compounded)$100/mo (quarterly plan, compounded)
Tirzepatide$149/mo (starting dose, compounded)Not disclosed
CoverageCoverage not published45 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Harbor

Site position #94 · C

Factor scores not reassessed.

Strengths

  • Compounded semaglutide from $99/mo and tirzepatide from $149/mo — among the lowest headline prices in the market
  • LegitScript certified with 4.7-star rating, 94.6% success rate, and 10,000+ verified members
  • 24/7 physician access with ongoing consultations, dosage adjustments, and free discreet shipping
  • 12-Month Money Back Guarantee if you don't reach your weight-loss goal
  • HSA/FSA eligible; no hidden fees, no insurance billed

What to consider

  • Compounded medications are not FDA-approved; compounding pharmacy names not publicly disclosed
  • Dietitian support offered only post-program (maintenance phase), not during active treatment
  • State-specific consultation types vary; nationwide availability unconfirmed for all states
  • No labs disclosed; patient portal is a third-party platform (mdintegrations), not native
  • Newer brand; success rate and member counts are on-site claims, not third-party verified
Queen RX

Site position #210 · C

Factor scores not reassessed.

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

What to consider

  • LegitScript or PCAB accreditation has not been independently verified
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard